Barinthus Biotherapeutics plc annual total assets
2020
2021
2022
2023
2024
2025
Barinthus Biotherapeutics plc Total Assets Growth & History (BRNS)
Barinthus Biotherapeutics plc's total assets was $98.2M for fiscal 2025.
View full Barinthus Biotherapeutics plc company overviewBarinthus Biotherapeutics plc annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $98.2M | −$62.2M | −38.77% |
| 2024 | 2024-12-31 | $160.3M | −$54.2M | −25.26% |
| 2023 | 2023-12-31 | $214.5M | −$55.7M | −20.61% |
| 2022 | 2022-12-31 | $270.2M | −$10.5M | −3.74% |
| 2021 | 2021-12-31 | $280.7M | $230.0M | +454.05% |
| 2020 | 2020-12-31 | $50.7M | — | — |
Barinthus Biotherapeutics plc quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $81.9M | −$47.7M | −36.79% |
| Q1 2026 | 2026-03-31 | $92.1M | −$49.9M | −35.11% |
| Q4 2025 | 2025-12-31 | $98.2M | −$62.2M | −38.77% |
| Q3 2025 | 2025-09-30 | $109.2M | −$79.5M | −42.13% |
| Q2 2025 | 2025-06-30 | $129.6M | −$57.2M | −30.62% |
| Q1 2025 | 2025-03-31 | $142.0M | −$57.5M | −28.82% |
| Q4 2024 | 2024-12-31 | $160.3M | −$54.2M | −25.26% |
| Q3 2024 | 2024-09-30 | $188.7M | −$41.3M | −17.95% |
| Q2 2024 | 2024-06-30 | $186.7M | −$59.4M | −24.13% |
| Q1 2024 | 2024-03-31 | $199.5M | −$62.3M | −23.81% |
| Q4 2023 | 2023-12-31 | $214.5M | −$55.7M | −20.61% |
| Q3 2023 | 2023-09-30 | $230.0M | −$45.5M | −16.52% |
| Q2 2023 | 2023-06-30 | $246.1M | −$38.9M | −13.66% |
| Q1 2023 | 2023-03-31 | $261.8M | −$24.3M | −8.50% |
| Q4 2022 | 2022-12-31 | $270.2M | −$10.5M | −3.74% |
| Q3 2022 | 2022-09-30 | $275.5M | $18.9M | +7.37% |
| Q2 2022 | 2022-06-30 | $285.1M | $25.2M | +9.71% |
| Q1 2022 | 2022-03-31 | $286.1M | $119.6M | +71.85% |
| Q4 2021 | 2021-12-31 | $280.7M | $230.0M | +454.05% |
| Q3 2021 | 2021-09-30 | $256.6M | — | — |
| Q2 2021 | 2021-06-30 | $259.8M | — | — |
| Q1 2021 | 2021-03-31 | $166.5M | — | — |
| Q4 2020 | 2020-12-31 | $50.7M | — | — |
Barinthus Biotherapeutics plc total assets trends
Over the last five fiscal years, Barinthus Biotherapeutics plc's total assets increased from $50.7M to $98.2M, a change of $47.5M. The latest reported quarter, Q2 2026, shows $81.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Barinthus Biotherapeutics plc source filings ↗